Rolando Ochoa-Azze

A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial

Arturo Chang Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruíz et al. · The Lancet Regional Health - Americas · 2021 · 40 citations · Full text

A meningococcal B vaccine induces cross-protection against gonorrhea

Rolando Ochoa-Azze · Clinical and Experimental Vaccine Research · 2019 · 38 citations · Full text

A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity

Sonia Pérez-Rodríguez, Meiby Rodríguez-González, Rolando Ochoa-Azze et al. · Vaccine · 2022 · 31 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +7

A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and <i>Neisseria meningitidis</i> outer membrane vesicles

Darielys Santana-Mederos, Rocmira Pérez-Nicado, Yanet Climent-Ruíz et al. · RSC Chemical Biology · 2021 · 29 citations · Full text

Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial

Rolando Ochoa-Azze, Arturo Chang Monteagudo, Yanet Climent-Ruíz et al. · The Lancet Respiratory Medicine · 2022 · 29 citations · Full text

Vaccinology, Vaccine Safety, Vaccination +12